Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release

This publication has 17 references indexed in Scilit:

• Effect of Twice Daily Subcutaneous Administration of a Long-Acting Somatostatin Analog on 24-Hour Plasma Glucose Profiles in Patients with Insulin-Dependent Diabetes Mellitus
  Hormone and Metabolic Research, 1985
• Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus
  Metabolism, 1983
• SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
  Life Sciences, 1982
• Clinical evaluation of somatostatin as a potential adjunct to insulin in the management of diabetes mellitus
  Diabetologia, 1977
• Metabolic Effects of Somatostatin in Maturity-Onset Diabetes
  New England Journal of Medicine, 1977
• Somatostatin: Analogs with Selected Biological Activities
  Science, 1977
• The Diabetogenic Action of Somatostatin in Healthy Subjects and in Maturity Onset Diabetics*
  Journal of Clinical Endocrinology & Metabolism, 1977
• Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release
  Biochemical and Biophysical Research Communications, 1977
• Antidiabetic action of somatostatin--assessed by the artificial pancreas
  Diabetes, 1975
• Effects of Somatostatin on Plasma Glucose and Glucagon Levels in Human Diabetes Mellitus
  New England Journal of Medicine, 1974